Trials / Conditions / Cytomegalovirus Disease

Cytomegalovirus Disease

9 registered clinical trials studyying Cytomegalovirus Disease.

Status	Trial	Sponsor	Phase
Completed	Letermovir Use in Heart Transplant Recipients NCT04904614	Tufts Medical Center	Phase 4
Completed	A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection NCT04225923	Nobelpharma	Phase 2
Completed	MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese NCT04129398	Merck Sharp & Dohme LLC	Phase 3
Terminated	A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease NCT02439970	Jazz Pharmaceuticals	Phase 3
Terminated	A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus NCT02439957	Jazz Pharmaceuticals	Phase 3
Completed	Cut Off for the Diagnosis of Cytomegalovirus (CMV) Disease in Serum-positive Kidney Transplant Recipients NCT01573039	University of Sao Paulo General Hospital	—
Completed	Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection NCT01509404	Medical University of South Carolina	Phase 4
Completed	TT-CMV Observational Birth Cohort Study NCT00907686	Emory University	—
Unknown	Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients NCT00828503	Marcus Saemann	Phase 2